Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 22, 2018

SELL
$32.85 - $52.0 $492,750 - $780,000
-15,000 Closed
0 $0
Q1 2018

May 02, 2018

BUY
$29.98 - $46.35 $449,700 - $695,250
15,000 New
15,000 $467,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track American Assets Investment Management, LLC Portfolio

Follow American Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Assets Investment Management, LLC with notifications on news.